The rapid progress made over the last decade in bringing comprehensive genomic profiling to rare cancer patients has created the opportunity to significantly...
OnTarget
A Rare Cancer Blog
TRACK (Target Rare Cancer Knowledge) Virtual Molecular Tumor Board
The TRACK Study incorporates many features that make it unique and especially significant for rare cancer patients. One of these features is the Virtual...
Grief – You’re Back Again?
Written by Kristen Palma, TargetCancer Foundation President. Here is what I have learned about grief after having to cope with it for eleven years. It is...
Rare Cancer Research During COVID-19
By TCF research grant recipients Nabeel Bardeesy, PhD, of the Massachusetts General Hospital Cancer Center, and Adam Bass, MD of Dana-Farber Cancer...
My Story of Grief: Experiencing the loss of a loved one during COVID-19
By Kimberley Balkus, TCF volunteer and advocate 2,403 days. The number of days that my mom, Geri Keegan, lived with cholangiocarcinoma. She was given one year...
Breaking New Ground: FDA Approves Pemazyre, the First Targeted Therapy for Cholangiocarcinoma
In the midst of such a challenging time, I wanted to take a moment to share some very positive and exciting news with you. Late last week, the FDA granted...
In Julienne’s Footsteps: Climbing Mt. Kilimanjaro to Honor a Life
By guest writer Karen Dempsey The bonds that Julienne Morriss Callaway forged and the values she embraced in life have been instrumental in sustaining her...
An Insider’s Perspective
Dr. Monika Laszkowska, a gastroenterology fellow, next to the poster she presented at the 2019 TargetCancer Foundation Think Tank on Advancing...
2019 Cholangiocarcinoma Research Grant Announcement
TargetCancer Foundation is proud to announce a new two-year, $240,000 grant to the Bardeesy Lab at the Massachusetts General Hospital Cancer Center brings our...
Building the Tools of Cholangiocarcinoma Research – A Researcher’s Reflection.
In December 2019, TargetCancer Foundation announced $240,000 in new cholangiocarcinoma grant funding. The following post was written by Grant Recipient Nabeel...
10 Years Ago Today
Today TargetCancer Foundation remembers our founder, Paul Poth, whose life was taken by cholangiocarcinoma at age 39 on this day ten years ago- August 22,...
Teeing off for TargetCancer Foundation
By TargetCancer Foundation 2019 Summer Intern Ollie Cheever The fifth annual Matt Lindsay Memorial Golf Tournament tees off this Saturday, August 3rd, at the...
A Holiday Reflection
By Alie Plouff, TargetCancer Foundation Advocacy Council Member Like many things in life, grief isn’t black and white. In fact, it is mostly one large gray...
2018 NORD Summit: An Advocate’s Perspective
By Leslie Condon, TargetCancer Foundation Advocacy Council Chair The National Organization for Rare Disorders was formed after a small coalition of rare...
Team TargetCancer Foundation returns to the 2019 Boston Marathon!
We are happy to announce that Team TargetCancer Foundation will be making its fifth appearance in the Boston Marathon in 2019! We are excited to return to...